PLD2 Rabbit mAb

Catalog No.: F1493

    Filter:

    • WB
    • IHC
    • Lane 1: Hela
      Lane 2: A549
      Lane 3: HUVEC
    1/

    Experiment Essentials

    Subcellular Location: Cell membrane, Membrane.
    WB
    Recommending using RIPA/NP-40 Lysis Buffer to prepare lysates.

    Usage Information

    Dilution
    1:1000
    Application
    WB
    Source
    Rabbit
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
    Storage (from the date of receipt)
    –20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    95 kDa
    Positive Control human cortex; HeLa; A549; HUVEC
    Negative Control

    Expression & Treatment Conditions

    Sample Treatment Conditions
    293T Tansfection (hPLD2-Myc)
    Click to view more sample data

    *For predicted expression levels of this protein in various human-derived cells and tissues, please refer to: http://www.proteinatlas.org

    Exprimental Methods

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and transfer the cells into an EP tube. Wash the cells with ice-cold PBS twice. Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice.Add an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail), sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    818. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    Biological Description

    Specificity

    PLD2 Rabbit mAb recognizes endogenous levels of total PLD2 protein.

    Uniprot ID
    O14939
    Clone
    B7K12
    Background

    Phosphatidylcholine-specific phospholipase D (PLD) catalyzes the hydrolysis of phosphatidylcholine (PC) to generate choline and phosphatidic acid (PA), with PA serving as a precursor to the second messenger diacylglycerol (DAG). PLD exists in two main isoforms: PLD1 and PLD2. PLD2 is primarily localized at the plasma membrane under basal conditions, where it associates with receptors in lipid rafts, whereas PLD1 is found in perinuclear membranes and translocates to the plasma membrane upon cell stimulation. Activation of PLD2 is mediated by protein kinase C (PKC) and receptor (e.g., EGFR, PDGFR) and non-receptor tyrosine kinases (e.g., Src, JAK3), whereas PLD1 is activated by PKC, casein kinase-II, and small GTPases such as ARF and RHO. PLD2 exhibits higher basal activity compared to PLD1 and functions not only as a phospholipase but also as a guanine nucleotide exchange factor (GEF). PLD2 activity is modulated through complex phosphorylation and dephosphorylation pathways, primarily on tyrosine residues, involving interactions with proteins like S6K, Grb2, Sos, WASp, and Rac2. The PLD2 isoform is highly expressed in various cancers, including colorectal and breast cancers, and also acts as a GEF for the small GTPase Rac2, independent of its phospholipase function.

    References

    Tech Support

    Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3
    If you have any other enquiries, please leave a message.

    * Indicates a Required Field

    Please enter your name.
    Please enter your email. Please enter a valid email address.
    Please write something to us.